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The consumption of asparagus is associated with the production of malodorous urine with considerable interindividual
variability (IIV). To characterize the urinary odor kinetics after consumption of asparagus spears, we conducted a study with
consenting attendees from two American Society for Clinical Pharmacology and Therapeutics (ASCPT) meetings. Subjects
were randomized to eat a specific number of asparagus spears, and then asked to report their urinary odor perception.
Eighty-seven subjects were included in the final analysis. A mixed effect proportional odds model was developed that
adequately characterized the dose-response relationship. We estimated the half-life of the asparagus effect on malodorous
urine to be 4.7 hours (relative standard error (RSE)5 13.2%), and identified a dose-response slope term with good precision
(24.3%). Age was found as the predictor of IIV in slope estimates. This study design and tools can be used as a demonstration
‘‘crowdsourcing’’ project for studying population kinetics in organizational and educational settings.
CPT Pharmacometrics Syst. Pharmacol. (2018) 7, 34–41; doi:10.1002/psp4.12264; published online 14 December 2017.
Study Highlights
WHAT IS THE CURRENT KNOWLEDGE ON THE
TOPIC?
 The consumption of asparagus is associated with
the production and perception of malodorous urine with
considerable variability. Perceived urinary odor kinetics
after consumption of asparagus spears has not previ-
ously been characterized. In addition, there is a need
to educate more broadly on clinical pharmacology,
pharmacokinetics, and clinical trials.
WHAT QUESTION DID THIS STUDY ADDRESS?
 This crowdsourced clinical study aimed to character-
ize asparagus urinary odor perception kinetics and
associated variability in healthy subjects.
WHAT THIS STUDY ADDS TO OUR KNOWLEDGE
 A mixed effect proportional odds model was devel-
oped that adequately characterized the dose-response
relationship. The half-life of the effect of the number of
spears of asparagus consumed on the urinary odor
scores was approximately 4.7 hours. Age was a predic-
tor of variability in slope estimates.
HOW MIGHT THIS CHANGE DRUG DISCOVERY,
DEVELOPMENT, AND/OR THERAPEUTICS?
 Asparagus consumption and quantitative measure-
ment of malodorous urine perception provides a unique
opportunity to study and educate on important topics
related to pharmacokinetics and clinical trials. This
study design and tools can be used as a demonstra-
tion “crowdsourcing” project for studying population
kinetics in organizational and educational settings.
Asparagus is a vegetable that has been eaten by humans for
thousands of years. The production of odorous urine after
consumption of asparagus is well-known, and is associated
with significant interindividual variability (IIV) in the ability to
produce and/or detect the odor.1–3 The reported odor,
described as the smell of rotten cabbage, is attributed to the
production of volatile sulfurous metabolites.2 A number of sul-
fated asparagus metabolites, including methanethiol, dimethyl
disulfide, dimethyl sulfide, dimethyl sulfone, and dimethyl
trisulfide, have been found in the urine of individuals who con-
sumed asparagus. However, there is no consensus on which
compounds contribute to the distinct smell.4,5 Additionally, not
all individuals produce these sulfurous metabolites (i.e., they
are “nonexcretors”) and not all individuals who produce mal-
odorous urine may be able to perceive it (i.e., they are
“nonperceivers”).1,5–7
The cause(s) for variability in the production and perception
of malodorous urine after consuming asparagus has not been
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clearly elucidated. Genetic variability is likely to contribute to
the heterogeneity observed in the population. First, genetic
variability in drug or xenobiotic metabolizing enzymes can be
involved; however, no specific genes or enzymes involved in
the production of these metabolites have been identified so
far. Second, genetic variability in olfactory genes can be asso-
ciated with the inability to detect certain urinary asparagus
metabolites, also known as asparagus anosmia.5,8 In fact, a
recent genomewide association study involving 6,909 individu-
als identified 871 single nucleotide polymorphisms associated
with asparagus anosmia.9
At present, there is a need to educate more broadly on
the subjects of clinical pharmacology, pharmacokinetics,
and clinical trials. On the one hand, clinical pharmacology
training programs have declined and the public understand-
ing of clinical trial conduct is poor, while on the other hand,
quantitative approaches are increasingly being used in drug
discovery and development.10–13 Asparagus consumption
and quantitative assessment of malodorous urine, as mea-
sured by perceived odor, provides a unique opportunity to
study and educate on important topics related to pharmaco-
kinetics and conduct of clinical trials.
Here, we conducted, what we believe to be, the first ever
crowdsourced clinical study aimed to characterize aspara-
gus urinary odor kinetics and associated IIV in healthy sub-
jects. The novel aspects of the current study include
crowdsourcing of a population kinetic study, a semiquantita-
tive asparagus urine odor perception assessment, resulting
model-based analysis, and the educational aspects. The
study was conducted by involving attendees from two
American Society for Clinical Pharmacology and Therapeu-
tics (ASCPT) meetings in 2014–2015. The consenting
study participants were randomized to eat prepared aspara-
gus spears and report their perception of the odor in their
urine over a period of time. Odor production as measured
by the intensity of perceived odor was the pharmacody-
namic end point. The intensity of perceived odor was mea-
sured using an analog scale that subjectively measured the
magnitude of asparagus odor in urine. Data on demogra-
phy, dose, olfactory function, time of urine void, and odor
perceived were collected to understand the asparagus uri-
nary odor kinetics. The specific aims of this study were to
characterize the time course, dose-response dynamics, and
half-life (t1=2) of urinary asparagus odor perception after
receiving a single, specified dose of asparagus in a group
of subjects. This study design and the associated data
analysis can be used as a demonstration project for clinical
trials and population kinetics in many settings, including
schools, universities, and scientifically oriented organiza-
tions. In addition, there is a potential to link results through
crowdsourcing by allowing other researchers to add their
data to our dataset and build on the current analysis.
METHODS
Clinical studies
Two clinical studies were conducted: (1) a pilot study con-
ducted at an ASCPT subcommittee meeting (2014); and
(2) a main study at the ASCPT 2015 Annual Meeting. An
overview of these studies is provided in Supplementary
Table S1. As both the pilot and the main studies involved
participation of human subjects, the protocols, informed
consent forms, and instruction documents for the partici-
pants were reviewed and approved by the Integ Review
Institutional Review Board (IRB). The IRB approval was
sponsored by ICON.
The pilot study was conducted in October 2014 during an
ASCPT subcommittee meeting. In this open-label study,
consenting participants were randomized into one of the
four study groups to eat 0, 5, 10, or 15 spears of aspara-
gus. In order to evaluate general olfactory function, partici-
pants were also required to smell the contents of bottles
containing water (blank) and 2-mercaptoethanol (diluted to
0.5, 0.25, and 0.125 ppm with water), and to report on their
ability to smell the contents. The distinct odor of 2-
mercaptoethanol was detectable by most people at all three
nonhazardous concentrations of 2-mercaptoethanol.14 The
goal of the pilot study was to aid in the development of the
parameters and other logistics for the main study, including
qualifying the questionnaire scale used for reporting the
intensity of asparagus odor in urine. The differences
between the pilot study and the main study are outlined in
Supplementary Table S1. The supporting documents for
the pilot study (informed consent, CRFs, etc.) are not
included.
The main study was conducted at the March 2015
ASCPT Annual Meeting. In this open-label study, consent-
ing participants were randomized into one of the four study
groups to eat 0, 3, 6, or 9 spears of asparagus. The partici-
pants were asked to eat fewer asparagus spears based on
the participant reports from the pilot study. The participants
were instructed to eat the specified number of asparagus
spears within 15 minutes, and to document the actual
number of asparagus spears consumed in the demography
case report form (CRF; see Supplementary Materials S2
and S3). In order to evaluate general olfactory function,
participants were also required to smell the contents of two
bottles containing water and a commercially available per-
fume, and to report on their ability to smell the contents.
This switch was done in order to simplify the logistics for
the main study. Of note, the original intent of the olfactory
“challenge” was to distinguish perceivers from nonper-
ceivers using a compound (mercaptoethanol) with a similar
odor to the substance(s) responsible for malodorous urine
after asparagus consumption. When perfume replaced mer-
captoethanol in the main study, the olfactory “challenge”
became a test for nasal congestion. In the analysis, the
covariate for perfume/mercaptoethanol perception was uni-
formly positive in all study participants and the distinction
between perceivers and nonperceivers was assessed using
mixture modeling methods.
The demography CRF was required to be submitted at
the end of the opening reception after the participants were
randomized and ate the asparagus spears. The sample
CRFs were required to be completed after every micturition
to subjectively describe the intensity of the asparagus odor
on a scale of 0–6 (0 being no odor or not offensive and 6
being very intense or offensive odor). The participants had
the option of turning in the CRFs either in the digital or
paper format (Supplementary Material S3). To facilitate
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data handling and analyses, the study participants were
encouraged to use digital CRFs. Digital submission
required downloading the ASCPT Annual Meeting app on a
smart device and registering it for use. A free t-shirt was
offered to the first 100 asparagus study participants.
For data analysis, subjects were excluded from the analy-
sis if they did not report the time for asparagus consump-
tion or the number of spears consumed. Observation
records were excluded when the time of urination or the
odor perception score was missing.
The final, approved protocol is included as Supplemen-
tary Material S4.
Model development
Model development was conducted using NONMEM ver-
sion 7.3.15 The first order conditional estimation method
was used for parameter estimation. A mixed effect propor-
tional odds kinetic-pharmacodynamic model was used to
associate dose with odor scores.16,17 The relationship
between the number of asparagus spears consumed
(DoseAsparagus,i) for individual i and the associated effect
half-life (t1=2) was described as follows:
Ai t; ið Þ5DoseAsparagus;i  exp 2 ln 2t1=2;i
 t
 !
If yi,n represents the observed score for individual i and
observation n, then the probability to observe a score j
was defined as follows:
P yi ;n  j
 
5
efi;n
11efi ;n
fi,j is defined as the sum of baseline coefficient b1 and addi-
tional coefficients bn for the remaining m score levels, as
follows:
fi;j5
Xm
n51
bn1SAsp  Ai tð Þ
Here, SAsp is a dose-response slope parameter relating the
asparagus effect time course to the observed scores.
To estimate the probability of being a urinary odor per-
ceiver or nonperceiver, a mixture model was considered.
Nonperceivers were defined as individuals who consumed
asparagus but did not report a change in their urinary odor
(i.e., with a flat response curve). Estimation of IIV was con-
sidered for the parameters t1=2, baseline b1, and SAsp
according to log-normal distributions, except for b1, which
was modeled according to an additive relationship. Avail-
able participant demographics (age, sex, prior asparagus
consumption, and reported history of odor after eating
asparagus) were evaluated as predictors for IIV in parame-
ter estimates. Model selection was based on the decrease
in the objective function value (OFV), adequate parameter
estimation precision, and adequate description of the data
using visual predictive checks.18 The NONMEM model
code and final dataset are included as Supplementary
Materials S5 and S6, respectively.
RESULTS
Study participation and compliance
A total of 158 subjects signed the informed consent; how-
ever, only a total of 120 participants participated (14 and
106 in the pilot and main studies, respectively). After
excluding participants who did not report sufficient data, a
total of 87 participants had odor scores available, 79 of
whom received a nonzero dose of asparagus. A total of
412 odor scores were available for the data analysis.
With respect to compliance in data entry, 31% of the sub-
jects (43/137; note: 137 demography forms were submitted)
reported neither the nominally randomized nor the actual
number of spears consumed. With respect to compliance in
following the dose per protocol (i.e., eating the number of
spears a subject was randomized to), 12% of the subjects
(11/94) reporting their randomized number of spears did not
consume the assigned number of asparagus spears. Digital
CRFs were available only for the main study, and about
99% of the data submission was done via this mechanism.
The demographics of participants included in the analysis
are provided in Table 1; about 57% of the subjects were
women, and the age range was wide with a mean of 43
years (range, 24–64 years). The frequency of distribution of
the reported odor scores after the time of asparagus admin-
istration are provided in Figure 1a. The IIV for the duration
and magnitude of reported odor scores was clearly present,
as shown for representative individuals (Figure 1b). Individ-
ual curves are included as Supplementary Material S7.
Asparagus odor population kinetics
A six-score odor scale was used in this study. However, for
scores of four and five, we ultimately could only reliably esti-
mate a single coefficient due to insufficient data. The param-
eter estimates of the final model are shown in Table 2.
Because the majority of participants reported a change in
odor perception, perceivers could not be reliably separated
from nonperceivers. The half-life of the asparagus effect was
estimated at 4.7 hours, with good precision (relative standard
error (RSE)513%). A dose-response term (SAsp) could be
identified with good precision (24.3%), and found to be equal
for different score levels.
The IIV could be estimated for SAsp and for the baseline
variability of the score for responders (Table 2). The IIV
estimates for SAsp and baseline parameters were large:
56.1 of coefficient of variation percentage (CV%) and 63.1
CV%, respectively. The IIV could not be estimated simulta-
neously for both t1=2 and SAsp; a large correlation between
these parameters was present during estimation, as could
Table 1 Characteristics of participants included for the data analysis
No. of participants with evaluable data 87
No. of men/women 51/34a
Age, years (median, range) 41 (24–64)b
Known ability to smell odor after
eating asparagus (no.)
No (30), yes (57)
Consumed asparagus prior to study No (83), yes (4)
aSex was missing for 2 participants.
bAge was missing for 6 participants.
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be expected. Although estimation of IIV for t1=2 resulted in a
1 point drop in OFV, estimation of IIV for SAsp resulted in a
10 point drop in OFV, and IIV for SAsp was, therefore,
retained.
We evaluated collected demographics as predictors for
IIV in these parameters. Interestingly, a correlation between
age and SAsp was identified, and retained as covariate in
the model (Figure 2). The typical dose-response relation-
ship, as predicted by the model for different age groups, is
illustrated in Figure 3. The visual predictive check
(n52,000) indicated the model provided an adequate
description of the data (Figure 4).
DISCUSSION
We successfully conducted, what we believe to be, the first
ever crowdsourced population study to characterize the
kinetics in perception of urinary odor, dose response, and
IIV after asparagus consumption. The numbers of partici-
pants who were ultimately available for analysis were suffi-
cient to develop a population kinetic model, which
characterized a half-life, dose-response relationship, and
associated IIV for asparagus odor scores. For 5.7% of the
participants (5/87), a flat odor perception curve was
observed, and these individuals could potentially be
Figure 1 (a) Frequency counts of reported odor scores versus time after dose. (b) Representative selection of individual reported odor
scores vs. time.
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considered as nonperceivers. However, for several of these
individuals, only two observations were available, and, there-
fore, we did not separately distinguish between these popu-
lations in the analysis. The percentage of subjects who both
produce and perceive odorous urine after consuming aspar-
agus was within the range of previous observations.1,3,7
In addition to the main model-based analysis described,
we conducted an initial preliminary analysis using a simple
one-compartment model and treating the odor-rating scale
as a continuous variable. The t1=2 estimated in the preliminary
and final analyses had different meanings. In the preliminary
analysis, the t1=2 directly represented the rate of decline in
urine odor. In the present analysis, the t1=2 represented the
decline in the effect of the amount of asparagus eaten on
the logit of the probability of successive decreases in the
odor score. The preliminary model also required the estima-
tion of a “volume” term that served as a scalar between the
number of spears of asparagus eaten and the reported odor
score. The present model did not require a scalar term as
the effect of the amount of asparagus eaten (declining over
time with the reported t1=2) was incorporated as an element
in the logit transduction function and used to compute the
likelihoods of the odor scores in their (more appropriate)
ordered categorical domain.
This study was the first to quantify the t1=2 and the “dose”-
response for the effect of the number of consumed spears
on the intensity of asparagus-associated malodorous urine.
The t1=2 of the asparagus effect on malodorous urine was
4.7 hours. Moreover, we identified age to be correlated with
the individual estimate for the dose-response slope term. It
should be noted that IIV for t1=2 and the dose-response
slope were highly correlated. This age effect may be attrib-
utable to the decrease of renal function with age,19 result-
ing in odor time courses with increased intensity and
duration of perceived odors, as was illustrated in Figure 3.
Some of the parameter estimates were still associated
with significant uncertainty (e.g., baseline b1 and age effect);
more data could result in more precise estimates of these
parameters. Moreover, increasing the number of participants
could also provide additional insights in patient-associated
characteristics predictive of the kinetics of urinary odor pro-
files, and better separation of perceiver and nonperceiver
subgroups. Finally, collection of additional data may ulti-
mately allow explaining the IIV associated with the ability to
perceive odorous urine.
A pilot study with a small number of subjects helped with
ironing out the logistics of the study details. For example, in
the pilot study, the participants were randomized into one of
the four study groups selected to eat 0, 5, 10, or 15 spears
of asparagus. As the participants reported that eating 15
spears was a challenge, for the subsequent main study, the
dose was modified to 0, 3, 6, or 9 spears of asparagus. The
participants were asked to eat fewer asparagus spears
based on the participant reports from the pilot study. Also in
this study, to evaluate the olfactory function, participants
were asked to take a whiff (exposure duration of about 5–10
seconds) from the control bottles and 2-mercaptoethanol
dilutions (pilot study) or commercially available perfume
(main study). Ideally, the test of olfactory function should
have used sulfurous odor similar to the expected odor in
urine after consuming asparagus.
Table 2 Parameter estimates of the final kinetic-pharmacodynamic mixed effect proportional odds model
Description Parameter Estimate RSE (%) IIV (CV%)a
Structural model
Log, half-life of asparagus effect (h) t1=2 1.55 (ns 4.7 h) 13.2 –
Level 1, baseline b1 20.505 46.1 69.9b
Level 2 b2 20.861 13.8 –
Level 3 b3 20.889 13.3 –
Level 4 b4 21.41 15.5 –
Log, slope of asparagus effectb SAsp 20.879 (ns 0.42) 24.3 60.8
c
Effect of age on slopec AGE-SAsp 21.5 45 –
CV, coefficient of variation; IIV, interindividual variability; ns, normal (non-log) scale; RSE, relative standard error; t1=2, half-life.
aCalculated as sqrt(exp(OMEGA)-1).
bb1 for individual i given by b1,i5b11gb1.
cSlope for individual i given by SLOPEi5 exp(SAsp*(AGEi/41)
AGE-SASP1gSASP).
Figure 2 Relationship between individual predicted estimate for
slope and associated age of participant. The blue solid line indi-
cates the prediction for the effect of age on slope included in the
final model.
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One surprising observation from this study was that clini-
cal pharmacologists were not particularly compliant study
subjects. Usable data for this analysis was available from
72.5% of the subjects (n5 87/120) who participated in the
study, and this represented 55% of the subjects (n587/
158) who signed the informed consent to participate in the
study. In many instances, subjects did not report the time
of asparagus consumption, number of spears consumed,
time of urination, or odor perception score. In defense of
the subjects, free-format text fields were used in the case
report forms with no edit checks in place to prevent data
entry errors. The study team was unable to resolve the
resulting data queries as subjects departed for home after
the meeting and were lost to follow-up.
There were a number of lessons learned from the practical
execution of this study. First, as with many volunteer collabo-
rations,20 focus, organization, and pace of the project was a
challenge. Although ultimately successful, the overall project
duration was lengthy from design to completion. Mitigations
include robust project management with accountability, a
clear and concise project plan with precise objectives is man-
datory, and so are setting and adhering to deadlines. Sec-
ond, despite advertising before and at the annual meeting as
well as an incentive t-shirt, the rate of participation was rela-
tively low (about 10% of the annual meeting attendees) and
noncompliance was relatively high, especially given that
meeting participants were mostly scientists with keen interest
in clinical pharmacology and clinical trials. Mitigations might
also include increasing advertising, better explaining goals,
and offering additional incentives, such as a lottery. Finally,
the study itself was complicated and it may be possible to
simplify different elements in the future studies. For example:
(1) both digital and paper CRFs were offered, but the vast
majority of subjects used the digital option. In the future, only
the digital option would need to be offered; (2) the design of
the CRF could be improved by text controlling most field
entries to ensure uniformity of the entry data in order to
expedite data assembly; and (3) simplifying the odor scale.
In our analysis, we collapsed the upper two odor scores into
a single score because model parameters could not be reli-
ably estimated for these score levels separately. Therefore,
for subsequent studies, a five-point scale to quantify aspara-
gus odor perception may be sufficient.
This study and the associated data analysis could be
considered as a demonstration project for population kinet-
ics studies in many settings, including schools and a wide
variety of organizations. We have provided supplementary
materials as supportive documentation. Moreover, we also
provide the raw data and the code of the final model
developed (Supplementary Material S5). Unlike blood
concentrations of a drug, the questions about consumption
of asparagus and its associated malodorous urine are
straightforward and the endpoint—perception of malodor-
ous urine—is clear. Thus, the asparagus study can be uti-
lized to teach principles of pharmacokinetics and population
kinetics.
A recent trend in clinical trials is the “crowdsourcing” dif-
ferent aspects of clinical studies, such as mining and
Figure 3 Simulated median and interquartile range of dose-response relationship between the number of consumed asparagus spears
and the peak score (n52,000 individuals), for different age groups.
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analyzing clinical trial data and informing the design of a
clinical trial.21–23 The hope is that crowdsourcing, by har-
nessing the wisdom of the researcher, clinician, patient,
and advocate community, will lead to accelerated research
and development. In our study, we used crowdsourcing to
help with the logistics of the study, including running the
study, ensuring that informed consent was executed, pro-
viding instructions to the participants, aiding in randomiza-
tion, entering data from the paper CRFs, etc. Additionally,
we also hope to use crowdsourcing to build on the current
study. Our study design can be used as a demonstration
project for clinical trials and population kinetics in many set-
tings, including schools, universities, and scientifically ori-
ented organizations. Consequently, there is a potential to link
results through crowdsourcing by allowing other researchers
to add their data and build on the current database.
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